Weight Loss Induced by Bariatric Surgery Restricts Hepatic GDF15 Expression
Introduction. Obesity and related nonalcoholic fatty liver disease (NAFLD) are an emerging health care issue that imposes substantial morbidity to individuals. Growth and differentiation factor 15 (GDF15) limits food uptake, body weight, and energy balance by modulation of GDNF-family receptor α-lik...
Saved in:
Main Authors: | Timon E. Adolph (Author), Felix Grabherr (Author), Lisa Mayr (Author), Christoph Grander (Author), Barbara Enrich (Author), Alexander R. Moschen (Author), Herbert Tilg (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice
by: Henriette Frikke-Schmidt, et al.
Published: (2019) -
Using Infodemiology Metrics to Assess Public Interest in Liver Transplantation: Google Trends Analysis
by: Maria Effenberger, et al.
Published: (2021) -
Exercise increases circulating GDF15 in humans
by: Maximilian Kleinert, et al.
Published: (2018) -
GB18-06, a nanobody targeting GDF15, effectively alleviates weight loss and restores physical function in cachexia models
by: Yu Huang, et al.
Published: (2024) -
A long‐acting GDF15 analog causes robust, sustained weight loss and reduction of food intake in an obese nonhuman primate model
by: Songmao Zheng, et al.
Published: (2023)